4.7 Article

Optimization of the Linker Domain in a Dimeric Compound that Degrades an r(CUG) Repeat Expansion in Cells

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 63, Issue 14, Pages 7827-7839

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.0c00558

Keywords

-

Funding

  1. National Institutes of Health [DP1-NS096898, R35-NS116846-01, F31-NS110269]
  2. Department of Defense Peer-Reviewed Medical Research Program [W81XWH-18-0718]
  3. Muscular Dystrophy Association [380467]
  4. Myotonic U.S. Fellowship Research Grant
  5. National Ataxia Foundation Fellowship Research Grant

Ask authors/readers for more resources

RNA repeat expansions are responsible for more than 30 incurable diseases. Among them is myotonic dystrophy type 1 (DM1), the most common form of adult on-set muscular dystrophy. DM1 is caused by an r(CUG) repeat expansion [r(CUG)(exp)] located in the 3' untranslated region (UTR) of the dystrophia myotonica protein kinase gene. This repeat expansion is highly structured, forming a periodic array of 5'CUG/3'GUC internal loop motifs. We therefore designed dimeric compounds that simultaneously bind two of these motifs by connecting two RNA-binding modules with peptoid linkers of different geometries and lengths. The optimal linker contains two proline residues and enhances compound affinity. Equipping this molecule with a bleomycin A5 cleaving module converts the simple binding compound into a potent allele-selective cleaver of r(CUG)(exp). This study shows that the linker in modularly assembled ligands targeting RNA can be optimized to afford potent biological activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available